These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 36977486)

  • 21. Unraveling HDAC11: Epigenetic orchestra in different diseases and structural insights for inhibitor design.
    Khatun S; Prasad Bhagat R; Dutta R; Datta A; Jaiswal A; Halder S; Jha T; Amin SA; Gayen S
    Biochem Pharmacol; 2024 Jul; 225():116312. PubMed ID: 38788962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Histone/protein deacetylase 11 targeting promotes Foxp3+ Treg function.
    Huang J; Wang L; Dahiya S; Beier UH; Han R; Samanta A; Bergman J; Sotomayor EM; Seto E; Kozikowski AP; Hancock WW
    Sci Rep; 2017 Aug; 7(1):8626. PubMed ID: 28819166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The structural requirements of histone deacetylase inhibitors: SAHA analogs modified at the C5 position display dual HDAC6/8 selectivity.
    Negmeldin AT; Pflum MKH
    Bioorg Med Chem Lett; 2017 Aug; 27(15):3254-3258. PubMed ID: 28648461
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potent histone deacetylase inhibitors derived from 4-(aminomethyl)-N-hydroxybenzamide with high selectivity for the HDAC6 isoform.
    Blackburn C; Barrett C; Chin J; Garcia K; Gigstad K; Gould A; Gutierrez J; Harrison S; Hoar K; Lynch C; Rowland RS; Tsu C; Ringeling J; Xu H
    J Med Chem; 2013 Sep; 56(18):7201-11. PubMed ID: 23964961
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preparation of a new construct of human histone deacetylase 8 for the crystallization of enzyme-inhibitor complexes.
    Porter NJ; Christianson DW
    Methods Enzymol; 2019; 626():561-585. PubMed ID: 31606091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel Approaches Towards Designing of Isoform-Selective Inhibitors Against Class II Histone Deacetylases: The Acute Requirement for Targetted Anticancer Therapy.
    Ganai SA
    Curr Top Med Chem; 2016; 16(22):2441-52. PubMed ID: 26873193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histone deacetylase 11 suppresses p53 expression in pituitary tumor cells.
    Wang W; Fu L; Li S; Xu Z; Li X
    Cell Biol Int; 2017 Dec; 41(12):1290-1295. PubMed ID: 28782861
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and Biological Investigation of Oxazole Hydroxamates as Highly Selective Histone Deacetylase 6 (HDAC6) Inhibitors.
    Senger J; Melesina J; Marek M; Romier C; Oehme I; Witt O; Sippl W; Jung M
    J Med Chem; 2016 Feb; 59(4):1545-55. PubMed ID: 26653328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histone deacetylases: structural determinants of inhibitor selectivity.
    Micelli C; Rastelli G
    Drug Discov Today; 2015 Jun; 20(6):718-35. PubMed ID: 25687212
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Target Design of Novel Histone Deacetylase 6 Selective Inhibitors with 2-Mercaptoquinazolinone as the Cap Moiety.
    Bui HTB; Nguyen PH; Pham QM; Tran HP; Tran Q; Jung H; Hong QV; Nguyen QC; Nguyen QP; Le HT; Yang SG
    Molecules; 2022 Mar; 27(7):. PubMed ID: 35408604
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma cell dependence on histone/protein deacetylase 11 reveals a therapeutic target in multiple myeloma.
    Mostofa A; Distler A; Meads MB; Sahakian E; Powers JJ; Achille A; Noyes D; Wright G; Fang B; Izumi V; Koomen J; Rampakrishnan R; Nguyen TP; De Avila G; Silva AS; Sudalagunta P; Canevarolo RR; Siqueira Silva MDC; Alugubelli RR; Dai HA; Kulkarni A; Dalton WS; Hampton OA; Welsh EA; Teer JK; Tungesvik A; Wright KL; Pinilla-Ibarz J; Sotomayor EM; Shain KH; Brayer J
    JCI Insight; 2021 Dec; 6(24):. PubMed ID: 34793338
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery of Potent and Isoform-selective Histone Deacetylase Inhibitors Using Structure-based Virtual Screening and Biological Evaluation.
    Peng Z; Zhao Q; Tian X; Lei T; Xiang R; Chen L; Yang Y
    Mol Inform; 2022 Sep; 41(9):e2100295. PubMed ID: 35224862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HDAC11: a rising star in epigenetics.
    Liu SS; Wu F; Jin YM; Chang WQ; Xu TM
    Biomed Pharmacother; 2020 Nov; 131():110607. PubMed ID: 32841898
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HDAC11 inhibition disrupts porcine oocyte meiosis via regulating α-tubulin acetylation and histone modifications.
    Huang R; Sui L; Fu C; Zhai Y; Dai X; Zhang S; Li Z
    Aging (Albany NY); 2021 Mar; 13(6):8849-8864. PubMed ID: 33742608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibitory selectivity among class I HDACs has a major impact on inflammatory gene expression in macrophages.
    Cao F; Zwinderman MRH; van Merkerk R; Ettema PE; Quax WJ; Dekker FJ
    Eur J Med Chem; 2019 Sep; 177():457-466. PubMed ID: 31181405
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diarylcyclopropane hydroxamic acid inhibitors of histone deacetylase 4 designed by combinatorial approach and QM/MM calculations.
    Kollar J; Frecer V
    J Mol Graph Model; 2018 Oct; 85():97-110. PubMed ID: 30145395
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kinetic Tuning of HDAC Inhibitors Affords Potent Inducers of Progranulin Expression.
    Moreno-Yruela C; Fass DM; Cheng C; Herz J; Olsen CA; Haggarty SJ
    ACS Chem Neurosci; 2019 Aug; 10(8):3769-3777. PubMed ID: 31330099
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel Pyridine-Based Hydroxamates and 2'-Aminoanilides as Histone Deacetylase Inhibitors: Biochemical Profile and Anticancer Activity.
    Zwergel C; Di Bello E; Fioravanti R; Conte M; Nebbioso A; Mazzone R; Brosch G; Mercurio C; Varasi M; Altucci L; Valente S; Mai A
    ChemMedChem; 2021 Mar; 16(6):989-999. PubMed ID: 33220015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery of a potent histone deacetylase (HDAC) 3/6 selective dual inhibitor.
    Soumyanarayanan U; Ramanujulu PM; Mustafa N; Haider S; Fang Nee AH; Tong JX; Tan KSW; Chng WJ; Dymock BW
    Eur J Med Chem; 2019 Dec; 184():111755. PubMed ID: 31627059
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Class 1-Selective Histone Deacetylase (HDAC) Inhibitors Enhance HIV Latency Reversal while Preserving the Activity of HDAC Isoforms Necessary for Maximal HIV Gene Expression.
    Zaikos TD; Painter MM; Sebastian Kettinger NT; Terry VH; Collins KL
    J Virol; 2018 Mar; 92(6):. PubMed ID: 29298886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.